Retatrutide Cost and How to Get It

Updated July 29, 2026 · We may earn a commission from links on this page

Retatrutide has produced the largest weight reductions of any compound in trials, and it cannot be prescribed. That gap between demand and availability is the entire reason this page exists. There are three routes, and they are genuinely different in cost, risk and legality.

Route 1: clinical trial enrollment

The TRIUMPH program is running Phase 3 trials across multiple countries and indications — obesity, obesity with knee osteoarthritis, obstructive sleep apnoea, and type 2 diabetes. Participation costs nothing, includes medical supervision and monitoring, and gives access to pharmaceutical-grade material.

The trade-offs are real: you may be randomized to placebo, eligibility criteria are strict (BMI thresholds, comorbidity requirements, exclusion for prior GLP-1 use in some protocols), and sites are geographically limited. Listings are searchable on ClinicalTrials.gov by compound name and location — this is the only route that is both free and supervised.

Route 2: wait for approval

Phase 3 trials in the program have completion dates running through 2026, which puts a regulatory submission and possible approval somewhere around 2027 on current expectations. When it arrives, expect pricing in line with other branded incretin drugs — $1,000 or more per month at list price, less with insurance coverage where it applies.

Route 3: research-grade material

This is what most people mean when they ask how to get it. Research chemical suppliers sell retatrutide as a lyophilized powder under a research-use-only designation. It is legal to sell in that category, it is not an approved medicine, and no regulator has evaluated the manufacturing or purity of any particular vial.

Two consequences follow. First, quality varies enormously between suppliers, which is why a batch-specific certificate of analysis is the thing to check — our supplier vetting guide covers how to read one. Second, there is no medical supervision, no label, and no dosing guidance, in a compound whose tolerability depends heavily on correct titration.

What it actually costs

Vial price is the number suppliers advertise and the least useful one. Because retatrutide is titrated across a wide range, consumption at 8 mg weekly is four times consumption at 2 mg weekly — the dose determines cost far more than the vendor does.

Weekly doseMonthly consumptionApprox. monthly cost
2 mg (starting)~8 mg$35 – $70
4 mg~16 mg$70 – $140
8 mg (target)~32 mg$150 – $300
12 mg (high)~48 mg$220 – $450

Larger vials and multi-vial orders usually improve cost per milligram more than switching suppliers does. Add the ancillaries — bacteriostatic water, insulin syringes, alcohol pads — which come to a small one-off cost but are not optional.

Price context

OptionMonthly costSupervisionQuality assurance
Clinical trial$0FullPharmaceutical grade
Research-grade retatrutide$35 – $300NoneSupplier COA only
Semaglutide (Wegovy, list)~$1,300FullFDA approved
Tirzepatide (Zepbound, list)~$1,060FullFDA approved

That price gap is the reason the gray market exists, and it is worth naming plainly: what you save in money you pay in supervision and quality assurance. Whether that trade is acceptable is a personal decision, but it should be a conscious one rather than a hidden one.

Approved alternatives worth considering first

If the goal is weight loss rather than retatrutide specifically, tirzepatide is approved, produced about 21% reduction at 72 weeks in SURMOUNT-1, and has a prescription pathway plus manufacturer savings programs that bring real-world cost well below list. Semaglutide has the deepest evidence base and cardiovascular outcome data. Our ranked comparison covers how they differ.

On legality. Selling research-labeled material is legal in the US. Buying it is generally not prosecuted, but imports can be seized at customs, it cannot be legally compounded, and rules differ substantially between countries. Nothing here is legal advice.
Recommended supplier · affiliate partner

Retatrutide (RTA) — 10 mg — American Peptides

If you are sourcing research-grade material, the batch COA is what separates suppliers. This is our affiliate partner: HPLC and mass spec published per batch, US-based fulfillment. Research use only.

Check Price →

We may earn a commission if you buy through this link (at no extra cost to you). Sold for research purposes only.

Frequently asked questions

How do you get retatrutide?

There are two legitimate routes and one gray one. You can enrol in a Phase 3 clinical trial, which is free and medically supervised; you can wait for approval, expected around 2027 based on the trial timelines; or you can buy research-grade material, which is legal to sell for laboratory use and is not an approved medicine.

How much does retatrutide cost per month?

At research-supplier prices, a 2 mg weekly protocol runs roughly $35–70 per month and an 8 mg protocol roughly $150–300, because dose drives consumption far more than vial price does. For comparison, approved GLP-1 medicines cost $500–1,300 per month without insurance.

Can a doctor prescribe retatrutide?

No. It has no FDA approval, so there is no legal prescription pathway in the United States. It also cannot be legally compounded as an approved-drug alternative, unlike the situation that existed for semaglutide during shortages.

When will retatrutide be approved?

Eli Lilly's Phase 3 TRIUMPH program has trials with completion dates through 2026, and analysts generally expect a regulatory submission followed by approval around 2027. That timeline can move in either direction.

Is it legal to buy retatrutide?

Selling it labeled for research use is legal in the United States. Buying it is generally not prosecuted, but importing unapproved drugs can result in customs seizure, and marketing it for human use is not legal. Legality also varies significantly by country.

Sources

Related guides

Research use only. Retatrutide is not approved for human use. This page is informational and is neither medical nor legal advice.